Cullen/Frost Bankers’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16M | Sell |
|
|||||
|
2025
Q2 | $14.4M | Buy |
|
|||||
|
2025
Q1 | $13.9M | Buy |
|
|||||
|
2024
Q4 | $10.8M | Sell |
|
|||||
|
2024
Q3 | $16.9M | Buy |
|
|||||
|
2024
Q2 | $14.2M | Buy |
|
|||||
|
2024
Q1 | $13.8M | Buy |
|
|||||
|
2023
Q4 | $6.54M | Buy |
|
|||||
|
2023
Q3 | $6.04M | Buy |
|
|||||
|
2023
Q2 | $5.27M | Buy |
|
|||||
|
2023
Q1 | $4.35M | Buy |
|
|||||
|
2022
Q4 | $3.39M | Buy |
|
|||||
|
2022
Q3 | $1.78M | Buy |
|
|||||
|
2022
Q2 | $1.63M | Buy |
|
|||||
|
2022
Q1 | $527K | Sell |
|
|||||
|
2021
Q4 | $613K | Sell |
|
|||||
|
2021
Q3 | $687K | Sell |
|
|||||
|
2021
Q2 | $738K | Sell |
|
|||||
|
2021
Q1 | $661K | Sell |
|
|||||
|
2020
Q4 | $1.01M | Sell |
|
|||||
|
2020
Q3 | $1.26M | Buy |
|
|||||
|
2020
Q2 | $1.02M | Buy |
|
|||||
|
2020
Q1 | $875K | Sell |
|
|||||
|
2019
Q4 | $1.35M | Sell |
|
|||||
|
2019
Q3 | $1.29M | Buy |
|
|||||
|
2019
Q2 | $1.2M | Buy |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | $1M | Buy |
|
|||||
|
2018
Q3 | $899K | Buy |
|
|||||
|
2018
Q2 | $810K | Buy |
|
|||||
|
2018
Q1 | $767K | Buy |
|
|||||
|
2017
Q4 | $286K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $223K | Sell |
|
|||||
|
2016
Q3 | $258K | Buy |
|
|||||
|
2016
Q2 | $238K | Sell |
|
|||||
|
2016
Q1 | $283K | Sell |
|
|||||
|
2015
Q4 | $294K | Sell |
|
|||||
|
2015
Q3 | $333K | Buy |
|
|||||
|
2015
Q2 | $357K | Buy |
|
|||||
|
2015
Q1 | $391K | Sell |
|
|||||
|
2014
Q4 | $365K | Buy |
|
|||||
|
2014
Q3 | $282K | Buy |
|
|||||
|
2014
Q2 | $223K | Hold |
|
|||||
|
2014
Q1 | $223K | Buy |
|